ClinicalTrials.Veeva

Menu

Surgical vs. Medical Treatment of Urge Urinary Incontinence in Women (URGE-I)

K

Klinikum der Universität Köln

Status and phase

Unknown
Phase 2
Phase 1

Conditions

Urge Urinary Incontinence

Treatments

Procedure: cesa/vasa
Drug: solifenacin

Study type

Interventional

Funder types

Other

Identifiers

NCT01737411
URGE-I (Other Identifier)
11-016

Details and patient eligibility

About

The purpose of this study is to determine if pelvic surgery can improve urge urinary incontinence in women more than standard medical treatment.

Full description

Urge Urinary Incontinence affects 30% of postmenopausal women. The etiology is unknown therefore treatment is symptomatic. For that purpose the nerval stimulation of the bladder muscle is interfered by several drugs, e.g. solifenacin.

We observed that the surgical repair of critical pelvic structures, i.e. the uteri-sacral ligaments (USL) can restore continence in a considerable number of patients.

In this study the surgical treatment is compared with the solifenacin treatment. According to outcome after three months patients who are still incontinent are referred to the opposite treatment group.

Outcome will be differentiated in cure (primary aim) and improvement of symptoms (secondary aim).

Enrollment

120 estimated patients

Sex

Female

Ages

40 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • urge urinary incontinence

Exclusion criteria

  • stress urinary incontinence
  • cancer disease of the females genital tract
  • pregnancy
  • neurologic/psychological reasons for incontinence
  • body weight >100kg
  • previous urogynecological surgery (TVT)
  • syndrome of dry overactive bladder (>20 micturitions within 24 hours)

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

120 participants in 2 patient groups

solifenacin
Active Comparator group
Description:
10 mg solifenacin per day for three months
Treatment:
Drug: solifenacin
cesa/vasa
Experimental group
Description:
repair of USL
Treatment:
Procedure: cesa/vasa

Trial contacts and locations

1

Loading...

Central trial contact

Peter S Mallmann, Phd; Wolfram H Jager, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems